Response of patients with hematological AD to second-line therapy
| . | Steroids only . | RTX . | Other . |
|---|---|---|---|
| ITP | CR (n = 1) | PR (n = 1) NN (n = 1) NN (n = 1) + azathioprine CR (n = 1) | PR (n = 1) plasma exchange |
| AIHA | NR (n = 1) PR (n = 2) CR (n = 2) | Azathioprine (n = 1) NN CSA (n = 1) CR | |
| Evans | NR (n = 1) + cyclophosphamide PR (n = 1) + CSA + tacrolimus CR (n = 1) + CSA + MMF PR (n = 1) CR (n = 2) + tacrolimus |
| . | Steroids only . | RTX . | Other . |
|---|---|---|---|
| ITP | CR (n = 1) | PR (n = 1) NN (n = 1) NN (n = 1) + azathioprine CR (n = 1) | PR (n = 1) plasma exchange |
| AIHA | NR (n = 1) PR (n = 2) CR (n = 2) | Azathioprine (n = 1) NN CSA (n = 1) CR | |
| Evans | NR (n = 1) + cyclophosphamide PR (n = 1) + CSA + tacrolimus CR (n = 1) + CSA + MMF PR (n = 1) CR (n = 2) + tacrolimus |
MMF indicates mycophenolate mofetil; and NN, response not known.